Rinvok 15mg tablet

Rinvoq 15 mg is an extended-release, oral prescription tablet made up of upadacitinib. It acts as a Janus kinase (JAK) inhibitor which suppresses the overactive immune system, thus reducing inflammation. It is used for treating different chronic diseases such as rheumatoid arthritis, psoriatic arthritis, atopic dermatitis (eczema) and ulcerative colitis. Key FactsActive Ingredient: Upadacitinib (15 mg)Drug Classification: Janus Kinase (JAK) Inhibitor (Not a Biologic)Primary Purpose: Suppresses targeted immune activity to minimize pain, joint damage, and skin inflammation.Standard Dosage: Usually one tablet of 15 mg once per day. It may be taken with or without food, but must be swallowed as a whole and not chewed or crushed.Conditions Managed: Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis (eczema), ulcerative colitis, Crohn’s disease, and giant cell arteritis.